MedPath

Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus

Phase 1
Conditions
Type 2 Diabetes Mellitus
Interventions
Dietary Supplement: Vitamin C
Registration Number
NCT01319734
Lead Sponsor
Al-Neelain University
Brief Summary

Null hypothesis:

No significant effect of vitamin C 500 mg Supplementation on the severity of micro-vascular complications of type 2 Diabetes Mellitus (DM).

Alternative hypothesis:

There is a significant effect of vitamin C 500mg supplementation on the severity of the micro-vascular complications of type 2DM.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • clinical diagnosis of type 2DM
  • patients in good health
  • receiving oral hypoglycemic drugs
Exclusion Criteria
  • Insulin dependent diabetes
  • receiving vitamin complex
  • smoking
  • renal disease
  • liver disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Vitamin C supplementation plus oral hypoglycemic agents armVitamin CThis group will receive vitamin C supplementation 500mg daily for one month and then assessment will done for the patients.
Type 2DM patients receiving oral hypoglycemic agents aloneglyburidethis group is the control group who receive oral hypoglycemic agents alone
Primary Outcome Measures
NameTimeMethod
improving the renal functionthe renal function will be measure at day 1 and after one month

vitamin c supplementation act as an antioxidants which reduce the oxidative stress and then can improve the renal function.

Secondary Outcome Measures
NameTimeMethod
Vitamin C can improve the visual fieldsthe visual field will be assesed at day 1 and after one month

the damage of the eye can be prevented by decreasing the oxidative stress in the eye, this can be accomplished by vitamin C.

Trial Locations

Locations (1)

Jaber abo aliz

πŸ‡ΈπŸ‡©

Khartoum, Sudan

Β© Copyright 2025. All Rights Reserved by MedPath